(Q42710907)
Statements
1 reference
A phase 2, double-blind, randomized, placebo-controlled, dose-escalation study to evaluate the efficacy, safety, and tolerability of naloxegol in patients with opioid-induced constipation (English)
1 reference
Lynn Webster
1 reference
Sunita Dhar
1 reference
Michael Eldon
1 reference
Lorianne Masuoka
1 reference
Jaakko Lappalainen
1 reference
Mark Sostek
1 reference
16 April 2013
1 reference
1 reference
154
1 reference
9
1 reference
1542-1550
1 reference
Identifiers
1 reference
1 reference